Show simple item record

dc.contributor.authorLeussis, Melanie P.
dc.contributor.authorMadison, Jon M.
dc.contributor.authorPetryshen, Tracey
dc.date.accessioned2012-11-08T16:44:52Z
dc.date.available2012-11-08T16:44:52Z
dc.date.issued2012-10
dc.date.submitted2012-06
dc.identifier.issn2045-5380
dc.identifier.urihttp://hdl.handle.net/1721.1/74600
dc.description.abstractBipolar disorder (BD) is a multi-factorial disorder caused by genetic and environmental influences. It has a large genetic component, with heritability estimated between 59-93%. Recent genome-wide association studies (GWAS) using large BD patient populations have identified a number of genes with strong statistical evidence for association with susceptibility for BD. Among the most significant and replicated genes is ankyrin 3 (ANK3), a large gene that encodes multiple isoforms of the ankyrin G protein. This article reviews the current evidence for genetic association of ANK3 with BD, followed by a comprehensive overview of the known biology of the ankyrin G protein, focusing on its neural functions and their potential relevance to BD. Ankyrin G is a scaffold protein that is known to have many essential functions in the brain, although the mechanism by which it contributes to BD is unknown. These functions include organizational roles for subcellular domains in neurons including the axon initial segment and nodes of Ranvier, through which ankyrin G orchestrates the localization of key ion channels and GABAergic presynaptic terminals, as well as creating a diffusion barrier that limits transport into the axon and helps define axo-dendritic polarity. Ankyrin G is postulated to have similar structural and organizational roles at synaptic terminals. Finally, ankyrin G is implicated in both neurogenesis and neuroprotection. ANK3 and other BD risk genes participate in some of the same biological pathways and neural processes that highlight several mechanisms by which they may contribute to BD pathophysiology. Biological investigation in cellular and animal model systems will be critical for elucidating the mechanism through which ANK3 confers risk of BD. This knowledge is expected to lead to a better understanding of the brain abnormalities contributing to BD symptoms, and to potentially identify new targets for treatment and intervention approaches.en_US
dc.description.sponsorshipStanley Medical Research Instituteen_US
dc.description.sponsorshipAvis and Clifford Barrus Medical Foundationen_US
dc.description.sponsorshipMassachusetts General Hospital (Executive Committee on Research)en_US
dc.description.sponsorshipBroad Institute (Stanley Center for Psychiatric Research)en_US
dc.publisherBioMed Central Ltden_US
dc.relation.isversionofhttp://dx.doi.org/10.1186/2045-5380-2-18en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0en_US
dc.sourceBioMed Central Ltden_US
dc.titleAnkyrin 3: genetic association with bipolar disorder and relevance to disease pathophysiologyen_US
dc.typeArticleen_US
dc.identifier.citationLeussis, Melanie P, Jon M Madison, and Tracey L Petryshen. “Ankyrin 3: Genetic Association with Bipolar Disorder and Relevance to Disease Pathophysiology.” Biology of Mood & Anxiety Disorders 2.1 (2012): 18.en_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.mitauthorPetryshen, Tracey
dc.relation.journalBiology of Mood & Anxiety Disordersen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2012-11-07T16:03:06Z
dc.language.rfc3066en
dc.rights.holderMelanie P Leussis et al.; licensee BioMed Central Ltd.
dspace.orderedauthorsLeussis, Melanie P; Madison, Jon M; Petryshen, Tracey Len
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record